Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Pharmacogenet Genomics. 2006 Oct;16(10):735–745. doi: 10.1097/01.fpc.0000230119.34205.8a

Table 2.

Quantitative analysis of CACNA1C splice variants in human heart left ventricle (n = 65) using fluorescently labeled primers or real-time PCR (labeled with #)

Locus Splice variants 65 samples measured individually
Pooled sample
from 65 heartsa
Pooled sample from
five normal heartsb
Functional consequencea(ref)
Mean ± SD (%) Range % (min to max)
1# E1a-E2 70 ± 7 47–87 67 71 Activated by PKC [15]
E1-E2 30 ± 7 13–53 33 29 Inhibited by PKC [15]
2 E2-E3 99.9 ± 0.1 99–100 100 100
E2-E3 + 4nt 0.04 ± 0.10 0–1 0 0 Frame shift
3 E6-E7 50 ± 3 40–59 52 53
E6-E7-12nt 50 ± 3 41–60 48 47
4a E7-E8/E8a-E9-E10 99 ± 1 91–100 95 96
E7-E9-E10 1 ± 1 0–9 3 3
E7-E10 0 0 2 1
4b# E7-E8 26 ± 12 13–91 25 15 Smooth muscle isoform, higher affinity for
DHP [18]
E7-E8a 74 ± 12 9–87 75 85 Cardiac isoform, lower affinity for DHP
[18]
5 E9-E10 98 ± 1 94–99 97 96
E9-E9*-E10 2 ± 1 0.6–6 3 4
6 E10-E11 99.0 ± 0.4 97–100 99 99
E10-E10*-E11 1.0 ± 0.5 0–3 1 1
7 E14-E15 75 ± 4 60–83 75 78
E14-E15-73nt 25 ± 4 17–40 25 22 Frame shift, hemi-channel [11]
8 E16-E17 99.0 ± 0.4 98–99 96 97
E16-E17 + 9nt 1 ± 0.4 0.2–2.3 4 3
E16-E17 + 12nt 0.2 ± 0.2 0–1 0.2 0.2
9a E20-E21/22-E23 99.0 ± 0.6 97–100 98 98
E20-E23 1.0 ± 0.6 0–2 2 2
9b# E20-E21 91 ± 2 81–94 89 87
E20-E22 9 ± 2 6–19 11 13 More sensitive to DHP [14]
10a E30-E34 0.2 ± 0.4 0–2 0.3 0.2 Nonfunctional channel [11]
E30-E33-E34 2 ± 1 1–7 1 0.6
E30-E31-E32-E34 1 ± 0.2 0–1 0.5 0.5
E30-E31-E32-6nt-E34 0.03 ± 0.06 0–0.3 0 0
E30-E31-E32-E33-E34 1.0 ± 0.5 0.3–3 1.00 1
E30-E31-E32-6nt-E33-E34 0.2 ± 0.2 0–1 0 0.2
E30-E31/E32-E33-E34 48 ± 8 16–63 50 42 Reference isoform [11]
E30-E32-6nt-E34 3 ± 1 1–6 3 2.9 A isoform, Change gating
property [11]
E30-E32-6nt-E33-E34 15 ± 2 11–26 10 20 B isoform,
E30-E31/E32-E34 24 ± 6 9–41 34 32 C isoform
10b# E30-E31 13 ± 6 5–33 20 19 Fetal isoform [19]
E30-E32 87 ± 6 67–95 80 81 Adult isoform [19]
11 E40-E41 96 ± 1 93–98 93 92
E40-E41 + 57nt 4 ± 1 2–7 7 8 Change gating property [13]
12 E44-E46 99 ± 3 90–100 99 98
E44-E45*-E46 1 ± 3 0–9 1 2
E44-E45-E46 0 0 0 0
E44-E45*-187nt-E46 0 0 0 0

Data represent the percentage of each splice variant of the total transcripts in each locus. Data are the mean ± SD of 65 samples, each was measured twice. PKC, protein kinase C; DHP, dihydropyridine.

a

Same amounts of cDNA from 65 heart tissues were pooled, and splice variants measured twice and the average was shown.

b

Same amounts of total RNA from five normal heart left ventricles were pooled, then the cDNA synthesized and the splice variants measured. Data are the average of two cDNA preparations.